REVELATION BIOSCIENCES, INC. Loss Contingency, Damages Sought, Value
REVELATION BIOSCIENCES, INC. (REVB) reported Loss Contingency, Damages Sought, Value of $5.80 million for the 3-month period ending 2024-06-30, per its 10-Q/A filed 2024-09-23.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LossContingencyDamagesSoughtValue · last filed 2024-09-23
- REVELATION BIOSCIENCES, INC. loss contingency, damages sought, value for the quarter ending 2024-06-30 was $5.80M.
| Period end | Loss Contingency, Damages Sought, Value 3 month | Loss Contingency, Damages Sought, Value 6 month |
|---|---|---|
| 2024-06-30 | $5.80M 10-Q/A · filed 2024-09-23 | $5.80M 10-Q/A · filed 2024-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |